Gary Khoo

Gary Khoo

Gary Khoo has worked in Biotechnology products for the last 15 years. His experiences ranges from process development for mammalian cell processes (recombinant proteins and antibodies), development and operations of mid and late stage clinical products, technology transfer, start-up and manufacturing of commercial products, CMO operations and manufacturing. He is currently the Head of Manufacturing at Shire Singapore. He holds a PhD. in Biochemical Engineering and spent most of his career in Europe and Singapore.

Upcoming Events
4th Biologics Manufacturing Asia 2017  14-16 February 2017, Singapore

The 4th Biologics Manufacturing Asia 2017 is a focused knowledge-sharing platform for bringing together local and  global biopharma, bioprocessing scientists & engineers, innovative biotech, biologics contract manufacturing organizations (CMO’s), solution providers and technocrats from Singapore, Korea, China, Taiwan, Japan, India, just to name a few, to convene on the best manufacturing practices in order to have access to faster, cheaper and better  biologic drugs at the Biomanufacturing Hub of Asia – Singapore. Read More

Biologistics World Asia 2017 14-16 February 2017, Singapore

Biologistics World Asia 2017 will be the MOST Targeted event in Asia that focuses on cold- chain logistics for biomedical products, medical devices and biobanks. With the mission to create Asia’s only and most focused biologistics and supply chain marketplace that can bring together all the key players to discuss, debate and brainstorm on the most pertinent issues affecting Asia’s logistics network for the biopharmaceutical industry. Read More

7th Annual Vaccine World Summit 2017  28 February – 1 March 2017, Pune, India


Vaccine World Summit is the most sought after vaccine industrial gathering for emerging market manufacturers. Led by overwhelming demand from the industry, we are bringing the 7th annual back to Pune, India. Vaccine World Summit 2017, will be THE DEFINITE meeting place for vaccine leaders from India and all other emerging markets.. Read More